Requirements

Presentation:
  • Duration: 20-25 minutes
  • Every group member should participate in the presentation
  • At least one extra paper should be included in the presentation to e.g., show that other groups found the same/opposite results, or the same method can be used in other systems or another method can be used to study the same process etc.
    Discussions:
  • Duration: 15-20 minutes
  • Every group member will be evaluated based on their participation

    Schedule

    DateArticlePresentingDiscussionsLocation
    21-5-2012 Review on therapeutic antibodies Grp 1 Grps 3 & 5 DDW 1.22
    21-5-2012 Inhibition of EGFR by Cetuximab Grp 2 Grps 4 & 6 DDW 1.22
    23-5-2012 Achour et al Grp 4 Grps 8 & 10 Kruyt Z409
    23-5-2012 Allen et al Grp 12 Grps 2 & 6 Kruyt Z409
    25-5-2012 Achour et al Grp 7 Grps 1 & 5 Kruyt Z409
    25-5-2012 Allen et al Grp 3 Grps 9 & 11 Kruyt Z409
    13-6-2012 Blokhuis et al Grp 5 Grps 7 & 11 BPRC, Rijswijk
    13-6-2012 de Groot et al Grp 6 Grps 8 & 10 BPRC, Rijswijk
    15-6-2012 Schmid et al Grp 9 Grps 1 & 3 DDW 1.22
    15-6-2012 Hazenberg et al Grp 8 Grps 2 & 12 DDW 1.22
    15-6-2012 Kosmrlj et al Grp 11 Grps 9 & 7 DDW 1.22
    25-6-2012 Flajnik & Kasahara 2010 Grp 10 Grps 4 & 12 Kruyt O307